Fixed dose combinations [Design Issues]

posted by kumarnaidu – Mumbai, India, 2014-03-19 11:43 (4486 d 06:52 ago) – Posting: # 12664
Views: 5,372

Dear All,
If we want to demonstrate BE for an FDC in which one drug is highly variable (CV>30%)and other one with CV ~20% then in this case should we opt scaled approach(replicate design) or 2x2 crosover design?

Kumar Naidu

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
350 visitors (0 registered, 350 guests [including 26 identified bots]).
Forum time: 19:35 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5